CN Patent

CN1767831A — 包含甲基纳曲酮的药物配方

Assigned to Progenics Pharmaceuticals Inc · Expires 2006-05-03 · 20y expired

What this patent protects

描述了用于施用甲基纳曲酮的稳定药物组合物及其制备方法。还提供了包括这些药物组合物的试剂盒。

USPTO Abstract

描述了用于施用甲基纳曲酮的稳定药物组合物及其制备方法。还提供了包括这些药物组合物的试剂盒。

Drugs covered by this patent

methylnaltrexone-bromide (METHYLNALTREXONE BROMIDE)

Patent Metadata

Patent number: CN1767831A
Jurisdiction: CN
Classification: —
Expires: 2006-05-03
Drug substance claim: No
Drug product claim: No
Assignee: Progenics Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.